Aug 27 (Reuters) - Drug companies Jazz (JAZZ.O), opens new tab and Hikma (HIK.L), opens new tab must face claims that they schemed to delay a generic version of Jazz’s blockbuster narcolepsy ...

Hikma has been provided with a generic drug user free act (GDUFA) goal date of 10 May, 2017. If the drug is eventually accepted by the FDA, Vectura will receive a further $11 million.

The acquisition includes a commercial portfolio and pipeline of differentiated products, a manufacturing facility in ...

The production limit for lisdexamfetamine was increased by 6,236 kilograms, which includes 1,558 kg to address increased ...

Hikma’s generic version of Xyrem only reached the market last year, following a 2017 settlement that the plaintiffs allege was an unlawful “reverse payment agreement” designed to delay ...

Drug overdoses killed nearly 110,000 people in the US in 2022, according to the latest US government figures. Hikma was accused of failing to monitor and report suspicious opioid orders from ...

Higher doses of ADHD medications including Adderall and Vyvanse may increase the risk of psychosis, a new study has found.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today welcomed Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), to its ...

The raised production limit follows the Food and Drug Administration's request in July, the DEA said in a notice on Tuesday.